| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-15 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-14 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-13 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.41 | 3e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-05 |